Sources | Names Used |
---|---|
CTRPv2 | docetaxel:tanespimycin (2:1 mol/mol) |
PharmacoGx | docetaxel:tanespimycin (2:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | FAM114A1 | CTRPv2 | pan-cancer | AAC | -0.25 | 8e-11 |
mRNA | CEP295NL | CTRPv2 | pan-cancer | AAC | -0.25 | 9e-11 |
mRNA | ANP32B | CTRPv2 | pan-cancer | AAC | 0.24 | 1e-10 |
mRNA | EXOSC8 | CTRPv2 | pan-cancer | AAC | 0.22 | 2e-10 |
mRNA | KHDRBS1 | CTRPv2 | pan-cancer | AAC | 0.22 | 2e-10 |
mRNA | SRSF7 | CTRPv2 | pan-cancer | AAC | 0.23 | 2e-10 |
mRNA | SMARCC1 | CTRPv2 | pan-cancer | AAC | 0.23 | 2e-10 |
mRNA | NASP | CTRPv2 | pan-cancer | AAC | 0.21 | 3e-10 |
mRNA | TIMP2 | CTRPv2 | pan-cancer | AAC | -0.24 | 4e-10 |
mRNA | ARHGAP19 | CTRPv2 | pan-cancer | AAC | 0.25 | 5e-10 |